Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?

Algeria North Africa Omicron SARS-CoV-2 clade genomics mutation annotation

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
18 Feb 2022
Historique:
received: 14 01 2022
revised: 14 02 2022
accepted: 15 02 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Here, we report a first comprehensive genomic analysis of SARS-CoV-2 variants circulating in North African countries, including Algeria, Egypt, Libya, Morocco, Sudan and Tunisia, with respect to genomic clades and mutational patterns. As of December 2021, a total of 1669 high-coverage whole-genome sequences submitted to EpiCoV GISAID database were analyzed to infer clades and mutation annotation compared with the wild-type variant Wuhan-Hu-1. Phylogenetic analysis of SARS-CoV-2 genomes revealed the existence of eleven GISAID clades with GR (variant of the spike protein S-D614G and nucleocapsid protein N-G204R), GH (variant of the ORF3a coding protein ORF3a-Q57H) and GK (variant S-T478K) being the most common with 25.9%, 19.9%, and 19.6%, respectively, followed by their parent clade G (variant S-D614G) (10.3%). Lower prevalence was noted for GRY (variant S-N501Y) (5.1%), S (variant ORF8-L84S) (3.1%) and GV (variant of the ORF3a coding protein NS3-G251V) (2.0%). Interestingly, 1.5% of total genomes were assigned as GRA (Omicron), the newly emerged clade. Across the North African countries, 108 SARS-CoV-2 lineages using the Pangolin assignment were identified, whereby most genomes fell within six major lineages and variants of concern (VOC) including B.1, the Delta variants (AY.X, B.1.617.2), C.36, B.1.1.7 and B.1.1. The effect of mutations in SAR-CoV-2 genomes highlighted similar profiles with D614G spike (S) and ORF1b-P314L variants as the most changes found in 95.3% and 87.9% of total sequences, respectively. In addition, mutations affecting other viral proteins appeared frequently including; N:RG203KR, N:G212V, NSP3:T428I, ORF3a:Q57H, S:N501Y, M:I82T and E:V5F. These findings highlight the importance of genomic surveillance for understanding the SARS-CoV-2 genetic diversity and its spread patterns, leading to a better guiding of public health intervention measures. The know-how analysis of the present work could be implemented worldwide in order to overcome this health crisis through harmonized approaches.

Identifiants

pubmed: 35208920
pii: microorganisms10020467
doi: 10.3390/microorganisms10020467
pmc: PMC8877871
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Cell. 2021 Apr 29;184(9):2372-2383.e9
pubmed: 33743213
J Adv Res. 2021 May;30:123-132
pubmed: 33262895
Clin Infect Dis. 2022 Jan 29;74(2):366-368
pubmed: 33961693
J Hazard Mater. 2022 Mar 5;425:127923
pubmed: 34906876
Science. 2021 Dec 24;374(6575):1544-1545
pubmed: 34941399
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Cell Rep. 2021 Jan 12;34(2):108630
pubmed: 33417835
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
NPJ Vaccines. 2020 Oct 8;5:96
pubmed: 33083031
N Engl J Med. 2014 Jun 26;370(26):2499-505
pubmed: 24896817
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Int J Mol Sci. 2021 Jun 23;22(13):
pubmed: 34201415
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Pathog Glob Health. 2020 Mar;114(2):64-67
pubmed: 32048560
Epidemiol Infect. 2021 May 10;149:e259
pubmed: 33966683
Gene. 2021 Oct 30;801:145843
pubmed: 34274478
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
Front Microbiol. 2020 Jul 22;11:1800
pubmed: 32793182
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Sci Rep. 2021 Jul 30;11(1):15729
pubmed: 34330988
Epidemiol Rev. 2019 Jan 31;41(1):69-81
pubmed: 31781765
Sci Rep. 2021 Mar 2;11(1):4956
pubmed: 33654164
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Biosaf Health. 2021 Apr;3(2):124-127
pubmed: 33558859
Biosens Bioelectron. 2021 Oct 15;190:113418
pubmed: 34119838
Science. 2020 Jul 17;369(6501):297-301
pubmed: 32471856
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
J Virol. 2021 Mar 1;:
pubmed: 33649194
BMJ. 2003 Jul 5;327(7405):36-40
pubmed: 12842956
Sci Rep. 2021 Apr 19;11(1):8435
pubmed: 33875719
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Natl Sci Rev. 2020 Jun;7(6):1012-1023
pubmed: 34676127
Lancet Infect Dis. 2019 Oct;19(10):1054-1055
pubmed: 31559955
Pathogens. 2021 May 21;10(6):
pubmed: 34064143
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
MedComm (2020). 2021 Dec 16;:
pubmed: 34957469
Science. 2021 Mar 12;371(6534):1139-1142
pubmed: 33536258
Genomics. 2020 Sep;112(5):3588-3596
pubmed: 32353474
J Med Virol. 2020 Jul;92(7):863-867
pubmed: 32297980
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Taha Menasria (T)

Department of Applied Biology, Faculty of Exact Sciences and Natural and Life Sciences, University of Larbi Tebessi, Tebessa 12002, Algeria.
Department of Microbiology, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.

Margarita Aguilera (M)

Department of Microbiology, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.

Classifications MeSH